BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 204 filers reported holding BEAM THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,871,522 | -29.3% | 119,398 | -6.1% | 0.00% | 0.0% |
| Q2 2023 | $4,061,688 | +148.9% | 127,206 | +138.7% | 0.00% | 0.0% |
| Q1 2023 | $1,631,587 | -69.9% | 53,285 | -61.6% | 0.00% | -50.0% |
| Q4 2022 | $5,424,752 | +1294.5% | 138,705 | +1600.0% | 0.00% | – |
| Q3 2022 | $389,000 | -74.6% | 8,159 | -79.4% | 0.00% | -100.0% |
| Q2 2022 | $1,531,000 | -59.4% | 39,552 | -39.9% | 0.00% | 0.0% |
| Q1 2022 | $3,768,000 | +22.5% | 65,758 | +70.4% | 0.00% | 0.0% |
| Q4 2021 | $3,075,000 | -27.5% | 38,584 | -20.9% | 0.00% | 0.0% |
| Q3 2021 | $4,241,000 | +13.7% | 48,751 | +68.3% | 0.00% | 0.0% |
| Q2 2021 | $3,729,000 | -47.1% | 28,970 | -67.1% | 0.00% | -50.0% |
| Q1 2021 | $7,054,000 | +297.2% | 88,129 | +305.1% | 0.00% | +100.0% |
| Q4 2020 | $1,776,000 | +1514.5% | 21,756 | +387.7% | 0.00% | – |
| Q3 2020 | $110,000 | -45.8% | 4,461 | -38.3% | 0.00% | – |
| Q2 2020 | $203,000 | +1350.0% | 7,235 | +804.4% | 0.00% | – |
| Q1 2020 | $14,000 | – | 800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $205,573,000 | 24.93% |
| HSG Holding Ltd | 796,089 | $69,268,000 | 6.22% |
| DC Investments Management, LLC | 21,010 | $1,828,000 | 3.41% |
| Redmile Group, LLC | 1,975,006 | $171,845,000 | 3.00% |
| Casdin Capital, LLC | 818,820 | $71,246,000 | 1.77% |
| Evolutionary Tree Capital Management, LLC | 44,390 | $3,862,000 | 1.71% |
| HHLR ADVISORS, LTD. | 1,448,161 | $126,004,000 | 1.65% |
| Nan Fung Group Holdings Ltd | 54,903 | $4,777,000 | 1.53% |
| ARK Investment Management | 6,841,722 | $595,298,000 | 1.43% |
| BRANDYWINE MANAGERS, LLC | 12,900 | $1,122,000 | 1.17% |